Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $27.51 +4.72%
Revenue Growth %: -23.8%
Financial Fact:
Total operating expenses: 36.9M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: -23.8%
Financial Fact:
Total operating expenses: 36.9M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of $0.06, $0.23 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $93.97 million versus the consensus estimate of $60.48 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASM International posts Q3 net income of €308.1m, raises 2027 revenue target
- AstraZeneca may start work on cancer vaccines, CEO says
- Travel + Leisure (TNL) PT Raised to $91 at Stifel
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
